VAHH CHEMICALS H1 : CONS NET PROFIT UP 80.7% AT ₹3.62 CR (YOY), UP 17.4% (QOQ). STRONG (ON 1ST LOOK)

Revenue up 56.5% at ₹25.86 Cr (YOY), down 2.9% (QOQ). PBT up 76.3% at ₹4.84 Cr (YOY), up 15.1% (QOQ); current tax ₹1.22 Cr. Chemicals standalone revenue up 87.3% at ₹19.48 Cr (YOY); PAT up 86.8% at ₹2.72 Cr v ₹1.46 Cr. Nutraceuticals subsidiary HSHS revenue ₹6.38 Cr; PAT ₹0.90 Cr for H1. IPO gross proceeds ₹13.45 Cr; ₹10.89 Cr utilised, ₹2.56 Cr unutilised as at 30 Sep 2026. Board approved ₹10 L investment in proposed WOS Vedant Nutrition (100% holding, cash consideration).

Vahh Chemicals Ltd

Open attachment

← Back to feed